Picone O, Fuchs F, Sénat M-V, Brisset S, Tachdjian G, Audibert F, Fernandez H, Frydman R
Inserm U782, université Paris-Sud, 92140 Clamart, France.
J Gynecol Obstet Biol Reprod (Paris). 2008 Jun;37(4):385-91. doi: 10.1016/j.jgyn.2007.11.030. Epub 2008 Jan 8.
The aim of this study is to determine the complications of third trimester amniocentesis for fetal karyotyping among women unwilling to accept the fetal loss risks of second trimester amniocentesis.
A retrospective study was carried out from January 1998 to December 2006 of 182 singleton pregnancies that underwent a late amniocentesis (after 32 weeks) for fetal karyotyping. The indications were integrated risk (maternal age, first trimester nuchal translucency, second trimester maternal serum markers) over 1/250 (n=68), isolated maternal age over 38 years (n=51), isolated abnormal second trimester biochemical markers (n=34), history of personal or familial a chromosomal abnormality (n=21) or maternal choice (n=8). Presence of fetal abnormalities at ultrasound or context of viral or parasitologic seroconversion as well as multiple pregnancies were considered as non-inclusion criteria.
Median maternal age and gestational age at sampling were 39 years (range 23-48) and 32.4 weeks (29.5-37.6). Median interval between amniocentesis and definitive results of amniocentesis on the one hand, and delivery on the on the hand were 15 days (7-42) and 47 days (8-69), respectively. There were no chromosomal abnormality and non-termination of pregnancy. Nine patients out of 182(5%) had a spontaneous labour followed by premature delivery before 37 weeks and six women (3.3%) among those nine displayed preterm premature rupture of membranes (PPROM). Four patients out of 182 (2%) gave birth before definitive karyotyping result but all of them had a direct fluorescence in situ hybridisation analysis with a normal karyotyping result known well before delivery.
The risk of preterm premature rupture of membrane is 3.3%, with a 5% risk of premature delivery before 37 weeks. This late procedure provides a safe reassurance to women who are unwilling to accept the risks of earlier amniocentesis. However, it should only be used in particular situation and in countries were legislation allows late termination of pregnancy.
本研究旨在确定在不愿接受孕中期羊膜穿刺术导致胎儿丢失风险的女性中,孕晚期羊膜穿刺术用于胎儿核型分析的并发症。
对1998年1月至2006年12月期间182例单胎妊娠进行回顾性研究,这些妊娠接受了晚期羊膜穿刺术(孕32周后)以进行胎儿核型分析。指征包括综合风险(母亲年龄、孕早期颈部透明带厚度、孕中期母亲血清标志物)大于1/250(n = 68)、母亲年龄大于38岁(n = 51)、孕中期生化标志物孤立异常(n = 34)、个人或家族染色体异常病史(n = 21)或母亲自主选择(n = 8)。超声检查发现胎儿异常、病毒或寄生虫血清学转换情况以及多胎妊娠被视为非纳入标准。
采样时母亲年龄中位数和孕周分别为39岁(范围23 - 48岁)和32.4周(29.5 - 37.6周)。羊膜穿刺术与羊膜穿刺术最终结果之间的间隔中位数为15天(7 - 42天),与分娩之间的间隔中位数分别为47天(8 - 69天)。未发现染色体异常且未终止妊娠。182例患者中有9例(5%)出现自然临产,随后在37周前早产,这9例中有6例(3.3%)发生胎膜早破(PPROM)。182例患者中有4例(2%)在羊膜穿刺术最终核型分析结果出来之前分娩,但所有患者均进行了直接荧光原位杂交分析,且在分娩前就已得知核型分析结果正常。
胎膜早破风险为3.3%,37周前早产风险为5%。这种晚期操作可为不愿接受早期羊膜穿刺术风险的女性提供安全保障。然而,它仅应在特定情况下以及在立法允许晚期终止妊娠的国家使用。